Strength of the evidence: Adjuvant therapy for resected pancreatic cancer

Journal of Gastrointestinal Surgery

Volumn 12, Issue 4, 2008, Pages 657-661

  Picozzi, Vincent J ^a   Pisters, Peter W T ^c   Vickers, Selwyn M ^d   Strasberg, Steven M ^b  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Adjuvant therapy; Pancreatic cancer; Pancreatic neoplasms; Postgraduate course

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; ARTICLE; EVIDENCE BASED MEDICINE; HUMAN; PANCREAS TUMOR;

CHEMOTHERAPY, ADJUVANT; EVIDENCE-BASED MEDICINE; HUMANS; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT;

EID: 40849127035     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11605-007-0446-y     Document Type: Article

References (11)

1. Jemal A, Murray T, Ward E, Samuels A, Tiwari RC, Ghafoor A, Feuer EJ, Thun MJ. Cancer statistics. CA Cancer J Clin 2005;55:10-30
2. Gastrointestinal Tumor Study Group. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer 1987;59:2006-2010
3. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A, Wils J. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999;230:776-782
4. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ, Buchler MW. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004;350:1200-1210
5. Regine WF, Winter KW, Abrams R, Safran H, Hoffman JP, Konski A, Benson AB, MacDonald JS, Willett CG, Rich TA. RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-FU vs. gemcitabine (G) for resected pancreatic adenocarcinoma. J Clin Oncol 2006;24(18S pt 1) (abstract 4007)
6. Oettle H, Post S, Neuhaus P, Gellert K, Langrehr J, Ridwelski K, Schramm H, Fahlke J, Zuelke C, Burkart C, Gutberlet K, Kettner E, Schmalenberg H, Weigang-Koehler K, Bechstein WO, Niedergethmann M, Schmidt-Wolf I, Roll L, Doerken B, Riess H. Adjuvant chemotherapy with gemcitabine vs. observation in patients undergoing curative-intent resection of pancreatic cancer: A randomized controlled trial. JAMA 2007;297:267-277
7. Bakkevold KE, Arnesjo B, Dahl O, Kambestad B. Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of Vater-Results of a controlled, prospective, randomised multicentre study. Eur J Cancer 1993;29A:698-703
8. Lygidakis NJ, Berberabe AE, Spentzouris N, Dedemadi G, Kalligas T, Loukas G, Sotiropoulou V. A prospective randomized study using adjuvant locoregional chemoimmunotherapy in combination with surgery for pancreatic carcinoma. Hepatogastroenterology 1998;45:2376-2381
9. Kosuge T, Kiuchi T, Mukai K, Kakizoe T. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. Jpn J Clin Oncol 2006;36:159-165
10. Newman EA, Simeone DM, Mulholland MW. Adjuvant treatment strategies for pancreatic cancer. J Gastrointest Surg 2006;10:916-926
11. Bergenfeldt M, Albertsson M. Current state of adjuvant therapy in resected pancreatic adenocarcinoma. Acta Oncol 2006;45:124-135